Bone sarcoma treatment statistics

'14-day / Two-week wait'

England meets the standard for their country on the percentage of patients first seen by a specialist within two weeks of urgent GP referral for suspected cancer.[1]

'Two-week wait' supports early diagnosis as spotting cancer early is important for improving survival, so it is important that patients with potential cancer symptoms are referred promptly.

'31-day wait'

Northern Ireland and Wales do not meet the standard for their country on the percentage of patients that receive their first cancer treatment within 31 days of a decision to treat.[2,3]

The speed at which patients receive their first treatment can have a positive outcome on their clinical outcome, so it is important that patients with cancer symptoms are treated promptly.

'62-day wait'

Northern Ireland does not meet the standard for their country on the percentage of patients receiving their first definitive treatment for cancer within two months of a GP referral for suspected cancer.[4]

The speed at which patients receive their first treatment can have a positive outcome on their clinical outcome, so it is important that patients with cancer symptoms are treated promptly.

Cancer waiting times coding and standards are different in each country and so comparisons should not be made between countries, only each country against their own measures.

Sarcoma Cancer, Waiting Times, UK countries, 2014-15

    England Wales Scotland Northern Ireland
'14-day wait': seen by specialist following referral Performance 94.2%      
Standard 93%      
Performance against standard Meets standard      
'31-day wait': receipt of first treatment following decision to treat Performance   96.8%   97.2%
Standard   98%   98%
Performance against standard   Does not meet standard   Does not meet standard
'62-day wait': receipt of first treatment following referral Performance       77.8
Standard       95%
Performance against standard       Does not meet standard

Data not available for '14-day wait' in Wales, Scotland or NI.
Data not available for '31- or 62-day wait' in England or Scotland.
Data too small for '62-day wait' in Wales.

See also

Cancer waiting times by UK by healthcare area, Local Authority or postcode

Learn about cancer waiting times data, codes and tumour groups

References

  1. NHS England. Cancer waiting times.  Accessed May 2015.
  2. StatsWales. Cancer waiting times. Accessed May 2015. 
  3. ISD Scotland. Cancer Waiting Times. Accessed June 2015. 
  4. Department of Health, Social Services and Public Safety. Cancer Waiting Times. Accessed June 2015.

About this data

Data is for UK, 2014-2015, ICD-10 C40-C41.

Cancer waiting times statistics are for patients who entered the health care system within financial year 2014-15. Bone sarcoma is part of the group 'Sarcoma' for cancer waiting times data. Codes vary per country but broadly include: bone and articular cartilage, Kaposi sarcoma, retroperitoneum and peritoneum, other connective and soft tissue, secondary cancers of retroperitoneum and peritoneum, secondary cancers of bone and bone marrow.

Last reviewed:

The National Cancer Patient Experience Survey monitors patients’ self-reported satisfaction with each step of the cancer pathway in England, providing information to drive improvements in cancer care.[1] The survey has been conducted annually since 2010.

Overall, most cancer patients in England report positive experiences of cancer care. However patient experience varies along the cancer pathway, and by gender, ethnicity, age, deprivation, and cancer type. Satisfaction scores tend to be higher for experiences with Clinical Nurse Specialists and other hospital staff, and lower for experiences with GPs and general practice staff. Patients who report more positive experiences of cancer diagnosis and treatment tend to be male, white, older, and less deprived.

See also

Results from the Cancer Patient Experience Surveys

References

  1. Department of Health. National Cancer Patient Experience Survey Programme: 2016 National Survey Report.

About this data

See the reports for details

Last reviewed:

Cancer stats explained

See information and explanations on terminology used for statistics and reporting of cancer, and the methods used to calculate some of our statistics.

Cancer stats explained

Citation

You are welcome to reuse this Cancer Research UK content for your own work.
Credit us as authors by referencing Cancer Research UK as the primary source. Suggested styles are:

Web content: Cancer Research UK, full URL of the page, Accessed [month] [year].
Publications: Cancer Research UK ([year of publication]), Name of publication, Cancer Research UK.
Graphics (when reused unaltered): Credit: Cancer Research UK.
Graphics (when recreated with differences): Based on a graphic created by Cancer Research UK.

When Cancer Research UK material is used for commercial reasons, we encourage a donation to our life-saving research.
Send a cheque payable to Cancer Research UK to: Cancer Research UK, 2 Redman Place, London, E20 1JQ or

Donate online

Acknowledgements

We are grateful to the many organisations across the UK which collect, analyse, and share the data which we use, and to the patients and public who consent for their data to be used. Find out more about the sources which are essential for our statistics.